Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Vignette Bio in the transaction, and Cooley represented Candid Therapeutics. Candid Therapeutics, a biotechnology company, acquired Vignette Bio...
Vignette Bio’s Merger with Candid Therapeutics
Colossal Biosciences’ $150M Series B Financing
Gunderson Dettmer represented Colossal Biosciences on the deal. Colossal Biosciences, a genetic engineering company, announced its $150 million Series B financing led by United States Innovative Technology...